Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominic Oliver

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
Frontiers in Psychiatry|May 13, 2026
Acceptability of cannabidiol as a treatment for people at clinical high risk for psychosisDominic Oliver, Edward Chesney, Phoebe Wallman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 15, 2022
Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratiosAmir Englund, Dominic Oliver, Edward Chesney, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 21, 2018
What causes psychosis? An umbrella review of risk and protective factorsJoaquim Radua, Valentina Ramella-Cravaro, John P A Ioannidis, et al.
Biological Psychiatry|February 26, 2024
Using Electronic Health Records to Facilitate Precision PsychiatryDominic Oliver, Maite Arribas, Benjamin I Perry, et al.
Translational Psychiatry|December 14, 2021
Natural Language Processing markers in first episode psychosis and people at clinical high-riskSarah E Morgan, Kelly Diederen, Petra E Vértes, et al.
Schizophrenia Research|September 21, 2020
Lower speech connectedness linked to incidence of psychosis in people at clinical high riskTom John Spencer, Bethany Thompson, Dominic Oliver, et al.
Pharmaceutics|January 8, 2025
Novel Lipid Formulation Increases Absorption of Oral Cannabidiol (CBD)Edward Chesney, Ndabezinhle Mazibuko, Dominic Oliver, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 15, 2025
Prevalence of clinically significant radiological abnormalities in people with first episode psychosisThomas J Reilly, Matt Butler, Ahmed Abdelsamie, et al.
Cannabis and Cannabinoid Research|December 9, 2022
Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover StudyLucy A Chester, Amir Englund, Edward Chesney, et al.
BMC Biology|April 16, 2025
Colorectal cancer progression to metastasis is associated with dynamic genome-wide biphasic 5-hydroxymethylcytosine accumulationBen Murcott, Floris Honig, Dominic Oliver Halliwell, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Frontiers in Psychiatry|May 13, 2026
Acceptability of cannabidiol as a treatment for people at clinical high risk for psychosisDominic Oliver, Edward Chesney, Phoebe Wallman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 15, 2022
Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratiosAmir Englund, Dominic Oliver, Edward Chesney, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 21, 2018
What causes psychosis? An umbrella review of risk and protective factorsJoaquim Radua, Valentina Ramella-Cravaro, John P A Ioannidis, et al.
Biological Psychiatry|February 26, 2024
Using Electronic Health Records to Facilitate Precision PsychiatryDominic Oliver, Maite Arribas, Benjamin I Perry, et al.
Translational Psychiatry|December 14, 2021
Natural Language Processing markers in first episode psychosis and people at clinical high-riskSarah E Morgan, Kelly Diederen, Petra E Vértes, et al.
Schizophrenia Research|September 21, 2020
Lower speech connectedness linked to incidence of psychosis in people at clinical high riskTom John Spencer, Bethany Thompson, Dominic Oliver, et al.
Pharmaceutics|January 8, 2025
Novel Lipid Formulation Increases Absorption of Oral Cannabidiol (CBD)Edward Chesney, Ndabezinhle Mazibuko, Dominic Oliver, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 15, 2025
Prevalence of clinically significant radiological abnormalities in people with first episode psychosisThomas J Reilly, Matt Butler, Ahmed Abdelsamie, et al.
Cannabis and Cannabinoid Research|December 9, 2022
Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover StudyLucy A Chester, Amir Englund, Edward Chesney, et al.
BMC Biology|April 16, 2025
Colorectal cancer progression to metastasis is associated with dynamic genome-wide biphasic 5-hydroxymethylcytosine accumulationBen Murcott, Floris Honig, Dominic Oliver Halliwell, et al.
Pageof 12